Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
FDNA and Centogene Announce First Grant of Molecular Testing Under the Face2Gene Unknown Forum Grant Program at the American Society of Human Genetics (ASHG) Annual Meeting
October 17, 2016
BUSINESS WIRE – “Collaboration between FDNA, the developer of the Face2Gene Suite and CENTOGENE, worldwide leader in genetic diagnostics, enabled the first grant of molecular testing for a patient with an unknown genetic disorder. The collaboration extends beyond financial support and includes the successful integration of Face2Gene LABS API with CENTOGENE’s bioinformatics pipeline to improve variant prioritization and analysis of patients with undiagnosed genetic disorders using deep phenotyping and facial analysis technology.”
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…